Home » Stocks » GHSI

Guardion Health Sciences, Inc. (GHSI)

Stock Price: $1.39 USD -0.02 (-1.42%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 34.20M
Revenue (ttm) 1.88M
Net Income (ttm) -8.89M
Shares Out 21.35M
EPS (ttm) -0.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $1.39
Previous Close $1.41
Change ($) -0.02
Change (%) -1.42%
Day's Open 1.40
Day's Range 1.37 - 1.42
Day's Volume 216,134
52-Week Range 0.99 - 8.40

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported ...

1 week ago - GlobeNewsWire

Guardion Health Sciences Inc. (NASDAQ: GHSI) is confident that its recent acquisition of Activ Nutritional LLC will be a strong catalyst for growth. The company successfully entered into an equity purch...

1 month ago - Benzinga

SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported ...

1 month ago - GlobeNewsWire

Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion

1 month ago - GlobeNewsWire

Acquisition to Transform and Strengthen Guardion's  Clinical Nutrition Product Portfolio

1 month ago - GlobeNewsWire

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medica...

1 month ago - GlobeNewsWire

Acquisition to Transform and Strengthen Guardion's  Clinical Nutrition Product Portfolio

2 months ago - GlobeNewsWire

Clinical Trial Intended to Demonstrate Improved Visual Function in Glaucoma Patients Taking GlaucoCetin® Clinical Trial Intended to Demonstrate Improved Visual Function in Glaucoma Patients Taking Glauc...

2 months ago - GlobeNewsWire

Company Provides Corporate Update and Overview of Growth Plans Company Provides Corporate Update and Overview of Growth Plans

4 months ago - GlobeNewsWire

Guardion Health Sciences is burning through its cash too fast. Be cautious with GHSI stock as the price won't rise without an acquisition.

4 months ago - InvestorPlace

SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported...

4 months ago - GlobeNewsWire

The company maintains its Nasdaq listing, but at a price.

4 months ago - The Motley Fool

Recent at-the-market financings and warrant exercises have netted a combined $37.2 million in 2021, providing an effective cash runway for program execution and acquisition strategy implementation

5 months ago - GlobeNewsWire

Some medical stocks gained momentum because of the pandemic, while others focus on high-reward challenges like cancer treatment. The post 7 Healthy Medical Stocks to Buy appeared first on InvestorPlace.

Other stocks mentioned: AMED, CRDF, FLGT, NTRA, OMI, TDOC
5 months ago - InvestorPlace

SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition...

6 months ago - GlobeNewsWire

There's an old saying that 'gaps refill'. And that means that these 7 penny stock Bubbles may be about to burst.

Other stocks mentioned: ABML, NMGRF, OBSV, SB, ISR, ZOM
6 months ago - InvestorPlace

SAN DIEGO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition...

6 months ago - GlobeNewsWire

Guardion Health Sciences (GHSI) is seeing a massive spike in its stock on Wednesday despite a lack of news concerning the company. The post GHSI Stock: 11 Things for Investors to Know About Guardion Hea...

6 months ago - InvestorPlace

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition...

7 months ago - GlobeNewsWire

SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition...

7 months ago - GlobeNewsWire

New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients” New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients”

9 months ago - GlobeNewsWire

SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its stockhold...

9 months ago - GlobeNewsWire

SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition...

9 months ago - GlobeNewsWire

SAN DIEGO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing an update to shareholders with regard to its business plans. In conj...

9 months ago - GlobeNewsWire

Annual stockholder meeting scheduled for Thursday, October 29, 2020

10 months ago - GlobeNewsWire

Ho Wah Genting Berhad Receives Product Registration Approval For Astramern Nutra V Ho Wah Genting Berhad Receives Product Registration Approval For Astramern Nutra V

11 months ago - GlobeNewsWire

Guardion Health Sciences, Inc.'s (GHSI) CEO Dr.

11 months ago - Seeking Alpha

Newly-Appointed CFO Andrew Schmidt Brings Extensive and Wide-Ranging Public Company Experience

1 year ago - GlobeNewsWire

The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests

1 year ago - GlobeNewsWire

Patent Application Will Add to Guardion’s Intellectual Property Portfolio

1 year ago - GlobeNewsWire

Fulfills Initial Order of Astramern from Astramune Sdn Bhd, a Subsidiary of Ho Wah Genting Berhad

1 year ago - GlobeNewsWire

San Diego, California, June 15, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced today that its Board of Directors has appointed Dr. David...

1 year ago - GlobeNewsWire

There are pockets of the stock market that look far too overvalued to ignore, and our deep learning algorithms paired with our Artificial Intelligence (“AI”) technology has identified the top short targ...

Other stocks mentioned: AVGR, KAR
1 year ago - Forbes

The market is powering through its third consecutive day of massive gains. Whether the market is too optimistic has been on the minds of many, considering how unstable the economy has been this year.

Other stocks mentioned: BAND, COF, EYPT, HTBX
1 year ago - Forbes

-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical densi...

1 year ago - GlobeNewsWire

– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session –

1 year ago - GlobeNewsWire

- acuMMUNE now available for sale in the United States through online platforms -

1 year ago - GlobeNewsWire

--Growing portfolio of synergistic assets and proprietary technologies

1 year ago - GlobeNewsWire

- No immediate effect on the Company’s Nasdaq listing or the trading of its common stock -

1 year ago - GlobeNewsWire

San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates, ma...

1 year ago - GlobeNewsWire

Shares of actively-traded penny stock Guardion Health Sciences Inc (NASDAQ: GHSI) are advancing after the company announced an agreement for developing an immuno-supportive formula.

1 year ago - Benzinga

Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system. The formula will be a unique and exclusive brand of HWGB

1 year ago - GlobeNewsWire

  Formulation will be First Nutraceutical Compound to be Introduced Under Guardion’s Recently Acquired NutriGuard Business Line

1 year ago - GlobeNewsWire

San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and products, ...

1 year ago - GlobeNewsWire

San Diego, CA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten publi...

1 year ago - GlobeNewsWire

San Diego, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 24,500,000 sha...

1 year ago - GlobeNewsWire

San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for addition...

1 year ago - GlobeNewsWire

 Study Results Show 40 Times Higher Blood Concentration Levels of Mesozeaxanthin From Lumega-Z, Guardion’s Flagship Medical Food, as compared to Standard AREDS2 Over-The-Counter Gel Caps

1 year ago - GlobeNewsWire

San Diego, California, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), through its newly-formed wholly-owned subsidiary, NutriGuard Form...

1 year ago - GlobeNewsWire

About GHSI

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatS... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Apr 5, 2019
Stock Exchange
NASDAQ
Ticker Symbol
GHSI
Full Company Profile

Financial Performance

In 2020, GHSI's revenue was $1.89 million, an increase of 109.30% compared to the previous year's $902,937. Losses were -$8.57 million, -21.20% less than in 2019.

Financial Statements